• Home
  • Company
  • Our Lead Product
  • Pipeline
  • News-Media
  • Contact Us
  • Home
  • Company
  • Our Lead Product
  • Pipeline
  • News-Media
  • Contact Us

News

Startseite » News
BIT Pharma Announces Positive Phase 2b Study Results for NicaPlant® in aneurysmal subarachnoid heamorrhage patients (aSAH) undergoing aneurysm clipping. 1. July 2022
Pipeline
BIT Pharma Announces Positive Phase 2b Study Results for NicaPlant® in aneurysmal subarachnoid heamorrhage patients (aSAH) undergoing aneurysm clipping.
PRESS INFORMATION 14. April 2021
Company
PRESS INFORMATION
BIT PHARMA TOP15 MOST PROMISING BIOTECH STARTUPS IN EUROPE 22. May 2020
Company
BIT PHARMA TOP15 MOST PROMISING BIOTECH STARTUPS IN EUROPE
JÖRG BREITENBACH INDUCTED into MEDICAL and BIOLOGICAL ENGINEERING ELITE 30. March 2020
Team
JÖRG BREITENBACH INDUCTED into MEDICAL and BIOLOGICAL ENGINEERING ELITE
NICAPLANT GRANTED ORPHAN MEDICINAL PRODUCT DESIGNATION 27. December 2019
Pipeline
NICAPLANT GRANTED ORPHAN MEDICINAL PRODUCT DESIGNATION
BIT PHARMA ANNOUNCES CHANGE IN MANAGEMENT 10. December 2019
Company
BIT PHARMA ANNOUNCES CHANGE IN MANAGEMENT
BIT PHARMA ANNOUNCES SUCCESSFUL COMPLETION OF NicaPlant PHASE IIa CLINICAL TRIAL 6. July 2019
Pipeline
BIT PHARMA ANNOUNCES SUCCESSFUL COMPLETION OF NicaPlant PHASE IIa CLINICAL TRIAL
LEAD PRODUCT
NicaPlant®
BIT PHARMA
Company
Lead Product
Pipeline
Team and Management
Scientific Literature
News-Media
Contact
LEGAL
Privacy Policy
Copyright

Funded by seed financing of the BMWFW, processed by Austria Wirtschafts Service.


BMWFW

Austria Wirtschaftsservice
© 2016 BIT Pharma. All Rights Reserved.
Contact Us

Send us an email for further inquiry.

Not readable? Change text.